増殖分化因子15(GDF−15)を使用して代謝障害を処置するまたは軽快させる方法

The disclosure relates to the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), as well as end-stage liver disease, hepatic steatosis (fatty liver), liver fibrosis, liver inflammation, liver cirrhosis, primary biliary cirrhosis (PBC), and hepatocellular...

Full description

Saved in:
Bibliographic Details
Format Patent
LanguageJapanese
Published 06.10.2021
Subjects
Online AccessGet full text

Cover

Loading…